Skip to content

Prescription cannabinoid care vs. a medical marijuana card

The words cannabis, CBD, recommendation, prescription, and compounding are often treated as if they mean the same thing. They do not. Here is the plain-language difference.

A painting of a woman in an armchair by a tall window, looking at her phone during a private telehealth visit

At a glance

A medical marijuana card generally refers to a state-regulated recommendation or certification that may let an eligible patient access that state’s medical-cannabis system. A prescription is an order for a regulated drug. Pharmacy compounding is a separate, patient-specific process that may occur only when the legal and clinical requirements are met.1

In this guide6 sections

Start with the pathway, not the product

Everdawn’s cannabis telemedicine pathway is coming soon. No consultation, certification, prescription, compounded preparation, or retail cannabis product is available through Everdawn today.

Similar language. Different rules

PathWhat it usually meansWhat it does not mean
Medical-cannabis recommendationA clinician certification or recommendation under a specific state program.It is not automatically a pharmacy prescription or nationwide authorization.
FDA-approved cannabinoid drugA prescription drug reviewed by FDA for specific labeled uses.Approval of one drug does not approve every CBD or cannabis product.
Patient-specific compounded preparationA preparation made by a licensed pharmacy for an identified patient based on a valid prescription, when permitted.Compounded drugs are not FDA-approved, and availability cannot be assumed.
Retail hemp or dispensary productA consumer product sold under applicable federal, state, and local rules.Retail availability is not proof of FDA approval, medical suitability, or a prescription standard.
A painting of four unbranded objects on separate stone tiles, standing for state access, prescription medicine, compounding, and retail products: a blank card, a pharmacy bottle, a dropper bottle, and a plain carton
A recommendation, an FDA-approved drug, a patient-specific compounded preparation, and a retail product follow different pathways.

“Hemp-derived” does not mean “approved medicine”

The 2018 Farm Bill removed hemp and its derivatives containing no more than the statutory delta-9 THC threshold from the federal Controlled Substances Act. It did not remove FDA’s authority over foods, supplements, cosmetics, and drugs containing cannabis-derived compounds.2

FDA states that it has approved one cannabis-derived CBD drug and several cannabis-related drugs for specific uses.2 Other CBD products are not made FDA-approved simply because they are hemp-derived, sold online, recommended by a clinician, or prepared by a pharmacy.

A video visit does not erase state lines

Telehealth can make a medical conversation more accessible, but the clinician must be appropriately licensed for the patient’s location and the service must comply with applicable state and federal requirements. State medical-cannabis rules, prescription rules, and pharmacy shipping rules can differ.

If Everdawn launches this pathway, the experience is intended to begin with health history, current medications and products, goals, interaction risks, and clinical eligibility. An independent licensed clinician would make any medical decision. No outcome or product would be guaranteed.

Ask five direct questions

  1. Is this a state certification, a prescription, or retail guidance?The service should say which path it offers.

  2. Who makes the medical decision?Look for the licensed professional medical entity and the clinician’s role.

  3. Who dispenses or sells the product?A pharmacy, dispensary, and retail store are not interchangeable.

  4. What does “compounded” mean here?Ask whether the preparation is patient-specific, who prescribed it, and which pharmacy makes it.

  5. What is known about interactions and evidence?A clinician should review medications, risks, alternatives, and the limits of the evidence.

References

  1. Source 1: FDA: Compounding and the FDA, questions and answers (opens in a new tab)fda.govBack to text
  2. Source 2: FDA: Regulation of cannabis and cannabis-derived products (opens in a new tab)fda.govBack to text

A number in the text links to the source for that statement.

This article is general educational information, not medical or legal advice. Laws and regulatory positions can change. Speak with an appropriately licensed clinician, pharmacist, or attorney about your specific circumstances.

Images are illustrations, not Everdawn members or clinicians.